Thus, it was concluded that TQ treatment results in downregulation of anti-apoptotic and pro-survival proteins which are transcriptionally regulated by the NF-κB and PI3K/Akt pathways, leading to a loss of CCA cell survival and proliferation. The gene discussed is AKT1; the disease is cholangiocarcinoma.